Burns - Epidemiology Forecast - 2032

Burns Understanding

Burns Overview

Burns Diagnosis

Burns Epidemiology Perspective

Burns Detailed Epidemiology Segmentation

• In 2021, total incident population of burn injuries that required medical treatment in seven major markets were reported to be 1,864,208.
• The number of hospitalized burn cases in the seven major market is expected to increase at an effective CAGR during the study period, i.e. 2019-2032.
• The estimates suggest the United States had highest incident population of burn injuries that required medical treatment with 661,900 cases in 2021.
• According to our analysis, after fire/flame (41%), scald was the foremost contributing cause for burn injuries in the US, occupying 31.4% of total incident cases of treatment taking burn injuries.
• Our analysis indicates that the majority of burn injury cases taking treatment are males. This is accompanied by the fact that major burn injuries occur at workplaces; thus, the burn injury cases in males are predominantly higher. There were 410,378 male and 251,522 female cases of treated burn injuries in 2021, in the US.
• In 2021, the severity-specific incident cases were 144,294; 386,550; 19,857; and 111,199 for first-degree, second-degree, third-degree, and unspecified, respectively in the United States.
• According to our assessments for the United States, the estimated cases of hospitalized burn patients in 2021 were 76,383.
• Among the EU5 countries, the UK had the highest incident population of burn patients that require medical treatment with 275,829 cases, followed by France (203,690 cases) and Spain (143,209 cases) in 2021. On the other hand, Italy had the lowest incident population (122,890).
• Japan had 328,255 incident cases of burn injuries requiring medical treatment in 2021, the second-highest of all other countries in 7MM after the US.

Scope of the Report

• The report covers the descriptive overview of Burns, explaining its causes, signs, and symptoms, and pathophysiology.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden.
• The report provides the segmentation of the disease epidemiology for 7MM by segmented by Incident Cases of Burn Patients Requiring Treatment, Gender-specific Incident Cases of Treated Burn Injuries, Etiology-specific Incident Cases of Treated Burn Injuries, Severity-specific Incident Cases of Treated Burn Injuries, and Incident Cases of Hospitalized Burn Patients.

Report Highlights

• 11-Year Forecast of Burns
• 7MM Coverage
• Incident Cases of Burn Patients Requiring Treatment
• Gender-specific Incident Cases of Treated Burn Injuries
• Etiology-specific Incident Cases of Treated Burn Injuries
• Severity-specific Incident Cases of Treated Burn Injuries
• Incident Cases of Hospitalized Burn Patients

Key Questions Answered

• What are the disease risk, burdens, and unmet needs of Burns?
• What is the historical Burns patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Burns at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Burns?
• Out of the countries mentioned above, which country would have the highest patient population of Burns during the forecast period (2022-2032)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?

Reasons to Buy

• Develop business strategies by understanding the trends shaping and driving the 7MM Burns epidemiology.
• Quantify patient populations in the 7MM Burns market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the severity specific cases of Burns.
• The Burns epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Burns epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan